All Stories

  1. De novo phosphatidylcholine synthesis is required for autophagosome membrane formation and maintenance during autophagy
  2. Post-radiotherapy apparent diffusion coefficient (ADC) in children and young adults with high-grade gliomas and diffuse intrinsic pontine gliomas
  3. Synthetic 4D-CT of the thorax for treatment plan adaptation on MR-guided radiotherapy systems
  4. Reproducibility of the lung anatomy under active breathing coordinator control: Dosimetric consequences for scanned proton treatments
  5. Quantitative evaluation of contrast agent uptake in standard fat-suppressed dynamic contrast-enhanced MRI examinations of the breast
  6. Detecting human melanoma cell re-differentiation following BRAF or heat shock protein 90 inhibition using photoacoustic and magnetic resonance imaging
  7. Breast MRI segmentation for density estimation: Do different methods give the same results and how much do differences matter?
  8. Visualizing whole-body treatment response heterogeneity using multi-parametric magnetic resonance imaging
  9. Rapid development of image analysis research tools: Bridging the gap between researcher and clinician with pyOsiriX
  10. Repeatability and sensitivity of measurements in patients with head and neck squamous cell carcinoma at 3T
  11. Evaluating the diagnostic sensitivity of computed diffusion-weighted MR imaging in the detection of breast cancer
  12. Response evaluation in mesothelioma: Beyond RECIST
  13. Quality assurance in MRI breast screening: comparing signal-to-noise ratio in dynamic contrast-enhanced imaging protocols
  14. Acting on incidental findings in research imaging
  15. Characterizing Heterogeneity within Head and Neck Lesions Using Cluster Analysis of Multi-Parametric MRI Data
  16. Detecting microvascular changes in the mouse spleen using optical computed tomography
  17. Diffusion-weighted MR imaging of metastatic abdominal and pelvic tumours is sensitive to early changes induced by a VEGF inhibitor using alternative diffusion attenuation models
  18. Evaluation of diffusion models in breast cancer
  19. Quantitative Contrast-Enhanced Magnetic Resonance Lymphangiography of the Upper Limbs in Breast Cancer Related Lymphedema: An Exploratory Study
  20. Prospective, longitudinal, multi-modal functional imaging for radical chemo-IMRT treatment of locally advanced head and neck cancer: the INSIGHT study
  21. Diffusion-weighted MR neurography for the assessment of brachial plexopathy in oncological practice
  22. Phase I Study of Nintedanib Incorporating Dynamic Contrast-Enhanced Magnetic Resonance Imaging in Patients With Advanced Solid Tumors
  23. Multi-centre reproducibility of diffusion MRI parameters for clinical sequences in the brain
  24. Single-shot single-voxel lactate measurements using FOCI-LASER and a multiple-quantum filter
  25. Demonstration of the reproducibility of free-breathing diffusion-weighted MRI and dynamic contrast enhanced MRI in children with solid tumours: a pilot study
  26. Acquired resistance to EGFR tyrosine kinase inhibitors alters the metabolism of human head and neck squamous carcinoma cells and xenograft tumours
  27. Magnetic Resonance Imaging Improves Breast Screening Sensitivity in BRCA Mutation Carriers Age ≥ 50 Years: Evidence From an Individual Patient Data Meta-Analysis
  28. First MRI application of an active breathing coordinator
  29. Evaluation of lactate detection using selective multiple quantum coherence in phantoms and brain tumours
  30. Use of the temporal median and trimmed mean mitigates effects of respiratory motion in multiple-acquisition abdominal diffusion imaging
  31. Investigating the Influence of Flip Angle and k-Space Sampling on Dynamic Contrast-Enhanced MRI Breast Examinations
  32. Interrogating Two Schedules of the AKT Inhibitor MK-2206 in Patients with Advanced Solid Tumors Incorporating Novel Pharmacodynamic and Functional Imaging Biomarkers
  33. Lactate and Choline Metabolites Detected In Vitro by Nuclear Magnetic Resonance Spectroscopy Are Potential Metabolic Biomarkers for PI3K Inhibition in Pediatric Glioblastoma
  34. Dichloroacetate induces autophagy in colorectal cancer cells and tumours
  35. Assessment of Treatment Response by Total Tumor Volume and Global Apparent Diffusion Coefficient Using Diffusion-Weighted MRI in Patients with Metastatic Bone Disease: A Feasibility Study
  36. MRI breast screening in high-risk women: cancer detection and survival analysis
  37. Clinical Proton MR Spectroscopy in Central Nervous System Disorders
  38. Quantitative PET and SPECT performance characteristics of the Albira Trimodal pre-clinical tomograph
  39. Development of a Hybrid Magnetic Resonance and Ultrasound Imaging System
  40. Profiling metabolite changes in the neuronal differentiation of human striatal neural stem cells using 1H-magnetic resonance spectroscopy
  41. Comparison of three reference methods for the measurement of intracellular pH using 31 P MRS in healthy volunteers and patients with lymphoma
  42. The role of pre-treatment diffusion-weighted MRI in predicting long-term outcome of colorectal liver metastasis
  43. Model Free Approach to Kinetic Analysis of Real-Time Hyperpolarized 13C Magnetic Resonance Spectroscopy Data
  44. Noninvasive Phosphorus Magnetic Resonance Spectroscopic Imaging Predicts Outcome to First-line Chemotherapy in Newly Diagnosed Patients with Diffuse Large B-Cell Lymphoma
  45. Acute tumour response to the MEK1/2 inhibitor selumetinib (AZD6244, ARRY-142886) evaluated by non-invasive diffusion-weighted MRI
  46. Stacked Autoencoders for Unsupervised Feature Learning and Multiple Organ Detection in a Pilot Study Using 4D Patient Data
  47. 1 H NMR and hyperpolarized 13 C NMR assays of pyruvate–lactate: a comparative study
  48. MEK1/2 Inhibition Decreases Lactate in BRAF-Driven Human Cancer Cells
  49. Multi-Frame SPRITE: A method for resolution enhancement of multiple-point SPRITE data
  50. Comparison of free-breathing with navigator-controlled acquisition regimes in abdominal diffusion-weighted magnetic resonance images: Effect on ADC and IVIM statistics
  51. Reproducibility of Dynamic Contrast-enhanced MR Imaging: Why We Should Care
  52. Improved intravoxel incoherent motion analysis of diffusion weighted imaging by data driven Bayesian modeling
  53. Optimal age to start preventive measures in women withBRCA1/2mutations or high familial breast cancer risk
  54. First-in-Human Phase I Trial of Two Schedules of OSI-930, a Novel Multikinase Inhibitor, Incorporating Translational Proof-of-Mechanism Studies
  55. The utility of whole-body diffusion-weighted MRI for delineating regions of interest in PET
  56. Critical research gaps and translational priorities for the successful prevention and treatment of breast cancer
  57. Breast dynamic contrast-enhanced examinations with fat suppression: Are contrast-agent uptake curves affected by magnetic field inhomogeneity?
  58. Functional imaging in adult and paediatric brain tumours
  59. Advanced Solid Tumors Treated with Cediranib: Comparison of Dynamic Contrast-enhanced MR Imaging and CT as Markers of Vascular Activity
  60. Informatics in Radiology: Development of a Research PACS for Analysis of Functional Imaging Data in Clinical Research and Clinical Trials
  61. Measurement reproducibility of perfusion fraction and pseudodiffusion coefficient derived by intravoxel incoherent motion diffusion-weighted MR imaging in normal liver and metastases
  62. Whole-Body Diffusion-Weighted MRI: Tips, Tricks, and Pitfalls
  63. Differences in Natural History between Breast Cancers in BRCA1 and BRCA2 Mutation Carriers and Effects of MRI Screening-MRISC, MARIBS, and Canadian Studies Combined
  64. Combination of chemical suppression techniques for dual suppression of fat and silicone at diffusion-weighted MR imaging in women with breast implants
  65. Phase I Trial of Combretastatin A4 Phosphate (CA4P) in Combination with Bevacizumab in Patients with Advanced Cancer
  66. Imaging vascular function for early stage clinical trials using dynamic contrast-enhanced magnetic resonance imaging
  67. Neuroendocrine Tumor Liver Metastases: Use of Dynamic Contrast-enhanced MR Imaging to Monitor and Predict Radiolabeled Octreotide Therapy Response
  68. Assessment of colorectal hepatic metastases by quantitative T2 relaxation time
  69. Common Breast Cancer Susceptibility Variants in LSP1 and RAD51L1 Are Associated with Mammographic Density Measures that Predict Breast Cancer Risk
  70. Effects of HSP90 inhibitor 17-allylamino-17-demethoxygeldanamycin (17-AAG) on NEU/HER2 overexpressing mammary tumours in MMTV-NEU-NT mice monitored by Magnetic Resonance Spectroscopy
  71. An evaluation of motion compensation strategies and repeatability for abdominal 1H MR spectroscopy measurements in volunteer studies and clinical trials
  72. Histone Deacetylase Inhibition Increases Levels of Choline Kinase   and Phosphocholine Facilitating Noninvasive Imaging in Human Cancers
  73. Computerized detection of breast lesions in multi-centre and multi-instrument DCE-MR data using 3D principal component maps and template matching
  74. Computed Diffusion-weighted MR Imaging May Improve Tumor Detection
  75. Exploiting tumor metabolism for non-invasive imaging of the therapeutic activity of molecularly targeted anticancer agents
  76. Phase I Trial of a Selective c-MET Inhibitor ARQ 197 Incorporating Proof of Mechanism Pharmacodynamic Studies
  77. Assessment of the effect of haematocrit-dependent arterial input functions on the accuracy of pharmacokinetic parameters in dynamic contrast-enhanced MRI
  78. Analysis of Cancer Metabolism by Imaging Hyperpolarized Nuclei: Prospects for Translation to Clinical Research
  79. Psychological impact and acceptability of magnetic resonance imaging and X-ray mammography: the MARIBS Study
  80. A Bayesian hierarchical model for DCE-MRI to evaluate treatment response in a phase II study in advanced squamous cell carcinoma of the head and neck
  81. Noninvasive detection of carboxypeptidase G2 activity in vivo
  82. Dynamic contrast-enhanced MRI of neuroendocrine hepatic metastases: A feasibility study using a dual-input two-compartment model
  83. The Phosphoinositide 3-Kinase Inhibitor PI-103 Downregulates Choline Kinase α Leading to Phosphocholine and Total Choline Decrease Detected by Magnetic Resonance Spectroscopy
  84. Robustness of interactive intensity thresholding based breast density assessment in MR-mammography
  85. Metabolic assessment of the action of targeted cancer therapeutics using magnetic resonance spectroscopy
  86. A phase I study of the nitroimidazole hypoxia marker SR4554 using 19F magnetic resonance spectroscopy
  87. Assessing the usefulness of a novel MRI-based breast density estimation algorithm in a cohort of women at high genetic risk of breast cancer: the UK MARIBS study
  88. Hyperpolarized 13 C magnetic resonance detection of carboxypeptidase G2 activity
  89. Cancers in BRCA1 and BRCA2 Carriers and in Women at High Risk for Breast Cancer: MR Imaging and Mammographic Features 1
  90. Motion artifact correction in free-breathing abdominal MRI using overlapping partial samples to recover image deformations
  91. Phase-cycled averaging for the suppression of residual magnetisation in SPI sequences
  92. Eligibility for Magnetic Resonance Imaging Screening in the United Kingdom: Effect of Strict Selection Criteria and Anonymous DNA Testing on Breast Cancer Incidence in the MARIBS Study
  93. Quantitative imaging biomarkers in neuro-oncology
  94. Reproducibility and changes in the apparent diffusion coefficients of solid tumours treated with combretastatin A4 phosphate and bevacizumab in a two-centre phase I clinical trial
  95. A novel technique to monitor carboxypeptidase G2 expression in suicide gene therapy using19F magnetic resonance spectroscopy
  96. Modulation of choline kinase activity in human cancer cells observed by dynamic31P NMR
  97. Modulating the relaxivity of hyperpolarized substrates with gadolinium contrast agents
  98. An Exploratory Study Into the Role of Dynamic Contrast-Enhanced Magnetic Resonance Imaging or Perfusion Computed Tomography for Detection of Intratumoral Hypoxia in Head-and-Neck Cancer
  99. Changes in choline metabolism as potential biomarkers of phospholipase C 1 inhibition in human prostate cancer cells
  100. Optimizing functional parameter accuracy for breath-hold DCE-MRI of liver tumours
  101. Dynamic contrast-enhanced MRI for prostate cancer localization
  102. Breast cancer screening in women at high risk using MRI
  103. 80 POSTER Inhibition of MEK1/2 signalling results in decreased levels of intracellular lactate in human melanoma and colorectal cancer cells as observed with magnetic resonance spectroscopy
  104. A Pilot Study of Compositional Analysis of the Breast and Estimation of Breast Mammographic Density Using Three-Dimensional T1-Weighted Magnetic Resonance Imaging
  105. The value of magnetic resonance spectroscopy in tumour imaging
  106. Noninvasive Magnetic Resonance Spectroscopic Pharmacodynamic Markers of a Novel Histone Deacetylase Inhibitor, LAQ824, in Human Colon Carcinoma Cells and Xenografts
  107. Therapeutic Target Metabolism Observed Using Hyperpolarized15N Choline
  108. Quantitative mapping of hepatic perfusion index using MR imaging: a potential reproducible tool for assessing tumour response to treatment with the antiangiogenic compound BIBF 1120, a potent triple angiokinase inhibitor
  109. Computationally efficient vascular input function models for quantitative kinetic modelling using DCE-MRI
  110. Detection of colorectal hepatic metastases using MnDPDP MR imaging and diffusion-weighted imaging (DWI) alone and in combination
  111. BRCA1 Mutation and Young Age Predict Fast Breast Cancer Growth in the Dutch, United Kingdom, and Canadian Magnetic Resonance Imaging Screening Trials
  112. Distortion-correctedT2weighted MRI: a novel approach to prostate radiotherapy planning
  113. Registration of dynamic contrast-enhanced MRI using a progressive principal component registration (PPCR)
  114. Multiscale analysis of MR-mammography data
  115. Selective homonuclear Hartmann–Hahn for13C→13C polarization transfer in solution state NMR
  116. EU Directive 2004/40: field measurements of a 1.5 T clinical MR scanner
  117. Bayesian estimation of pharmacokinetic parameters for DCE-MRI with a robust treatment of enhancement onset time
  118. Predicting Response of Colorectal Hepatic Metastasis: Value of Pretreatment Apparent Diffusion Coefficients
  119. Quantitative evaluation of free-form deformation registration for dynamic contrast-enhanced MR mammography
  120. Reference tissue quantification of DCE-MRI data without a contrast agent calibration
  121. Conformational exchange in pimonidazole—a hypoxia marker
  122. Dynamic MRI for imaging tumor microvasculature: Comparison of susceptibility and relaxivity techniques in pelvic tumors
  123. Measurements of occupational exposure to switched gradient and spatially-varying magnetic fields in areas adjacent to 1.5T clinical MRI systems
  124. Reproducibility of reference tissue quantification of dynamic contrast-enhanced data: comparison with a fixed vascular input function
  125. Cost-effectiveness of screening with contrast enhanced magnetic resonance imaging vs X-ray mammography of women at a high familial risk of breast cancer
  126. A test of performance of breast MRI interpretation in a multicentre screening study
  127. Applications of magnetic resonance spectroscopy in radiotherapy treatment planning
  128. MRI for breast cancer screening
  129. Evaluation of response to treatment using DCE-MRI: the relationship between initial area under the gadolinium curve (IAUGC) and quantitative pharmacokinetic analysis
  130. Magnetic resonance spectroscopy (MRS) in the investigation of cancer at The Royal Marsden Hospital and The Institute of Cancer Research
  131. Factors influencing the accuracy of biomechanical breast models
  132. Colorectal hepatic metastases: quantitative measurements using single-shot echo-planar diffusion-weighted MR imaging
  133. Minimally Invasive Pharmacokinetic and Pharmacodynamic Technologies in Hypothesis-Testing Clinical Trials of Innovative Therapies
  134. Prediction of Clinicopathologic Response of Breast Cancer to Primary Chemotherapy at Contrast-enhanced MR Imaging: Initial Clinical Results
  135. Magnetic Resonance Imaging Workbench: Analysis and Visualization of Dynamic Contrast-enhanced MR Imaging Data
  136. Application of the chirp z-transform to MRI data
  137. Evaluation of31P high-resolution magic angle spinning of intact tissue samples
  138. Identification of magnetic resonance detectable metabolic changes associated with inhibition of phosphoinositide 3-kinase signaling in human breast cancer cells
  139. In vivo31P MR spectral patterns and reproducibility in cancer patients studied in a multi-institutional trial
  140. Noninvasive Magnetic Resonance Spectroscopic Pharmacodynamic Markers of the Choline Kinase Inhibitor MN58b in Human Carcinoma Models
  141. Electromagnetic field exposure limitation and the future of MRI
  142. Inversion recovery measurements in the presence of radiation damping and implications for evaluating contrast agents in magnetic resonance
  143. A Phase I study of the angiogenesis inhibitor SU5416 (semaxanib) in solid tumours, incorporating dynamic contrast MR pharmacodynamic end points
  144. Adiabatic half-passage pulses for measuring the polarization of highly non-equilibrium spin-systems
  145. Effects of platinum/taxane based chemotherapy on acute perfusion in human pelvic tumours measured by dynamic MRI
  146. Localized COSY and DQF-COSY1H-MRS sequences for investigating human tibial bone marrow in vivo and initial application to patients with acute leukemia
  147. Dual-contrast echo planar imaging with keyhole: application to dynamic contrast-enhanced perfusion studies
  148. Evaluation of radiological features for breast tumour classification in clinical screening with machine learning methods
  149. A complete distortion correction for MR images: II. Rectification of static-field inhomogeneities by similarity-based profile mapping
  150. Identification of biliary metabolites of ifosfamide using 31P magnetic resonance spectroscopy and mass spectrometry
  151. Processing of radical prostatectomy specimens for correlation of data from histopathological, molecular biological, and radiological studies: a new whole organ technique
  152. Screening with magnetic resonance imaging and mammography of a UK population at high familial risk of breast cancer: a prospective multicentre cohort study (MARIBS)
  153. The assessment of antiangiogenic and antivascular therapies in early-stage clinical trials using magnetic resonance imaging: issues and recommendations
  154. A complete distortion correction for MR images: I. Gradient warp correction
  155. Antivascular cancer treatments: functional assessments by dynamic contrast-enhanced magnetic resonance imaging
  156. Proceedings of the Engineering and Physical Sciences Research Council Workshop—the development of functional imaging in the diagnosis, management and understanding of childhood brain tumours
  157. Quantitative assessment of the hepatic pharmacokinetics of the antimicrobial sitafloxacin in humans using in vivo19F magnetic resonance spectroscopy
  158. Burst imaging—Can it ever be useful in the clinic?
  159. Implementation and evaluation of CSI-localizedJ cross-polarization for detection of31P magnetic resonance spectra in vivo
  160. Micro-coils for MR spectroscopy by deep silicon etching
  161. Notices of Duplicate Publication
  162. Investigations in vivo of the effects of carbogen breathing on 5-fluorouracil pharmacokinetics and physiology of solid rodent tumours
  163. Methodological standardization for a multi-institutionalin vivo trial of localized31P MR spectroscopy in human cancer research.In vitro and normal volunteer studies
  164. Investigation of microenvironmental factors influencing the longitudinal relaxation times of drugs and other compounds
  165. Alignment of dynamic contrast-enhanced MR volumes of the breast for a multicenter trial: an exemplar grid application
  166. Multiscale entropy analysis in dynamic contrast-enhanced MRI
  167. Visualization of multivariate image data using image fusion and perceptually optimized color scales based on sRGB
  168. Effects of residual single-quantum coherences in intermolecular multiple-quantum coherence studies
  169. Monitoring temozolomide treatment of low-grade glioma with proton magnetic resonance spectroscopy
  170. Assessment of antiangiogenic and antivascular therapeutics using MRI: recommendations for appropriate methodology for clinical trials
  171. Magnetic Resonance Spectroscopic Pharmacodynamic Markers of the Heat Shock Protein 90 Inhibitor 17-Allylamino,17-Demethoxygeldanamycin (17AAG) in Human Colon Cancer Models
  172. Comparison of polarization transfer sequences for enhancement of signals in clinical31P MRS studies
  173. Ifosfamide pharmacokinetics and hepatobiliary uptake in vivo investigated using single- and double-resonance31P MRS
  174. Could assessment of glioma methylene lipid resonance byin vivo1H-MRS be of clinical value?
  175. Non-invasive study of human gall bladder bilein vivousing1H-MR spectroscopy
  176. Hyperpolarising 13C for NMR studies using laser-polarised 129Xe: SPINOE vs thermal mixing
  177. Radiotherapy treatment planning of prostate cancer using magnetic resonance imaging alone
  178. Validation of nonrigid image registration using finite-element methods: application to breast MR images
  179. Comparison of biomechanical breast models: a case study
  180. Finite-element based validation of nonrigid registration using single- and multilevel free-form deformations: application to contrast-enhanced MR mammography
  181. Human rectal adenocarcinoma: Demonstration of1H-MR spectra in vivo at 1.5 T
  182. Applications of sliding window reconstruction with cartesian sampling for dynamic contrast enhanced MRI
  183. Assessing changes in tumour vascular function using dynamic contrast-enhanced magnetic resonance imaging
  184. Reproducibility of quantitative dynamic MRI of normal human tissues
  185. Comparison and evaluation of rigid and nonrigid registration of breast MR images
  186. Focused ultrasound surgery-induced vascular occlusion in fetal medicine
  187. Visual detectability of elastic contrast in real-time ultrasound images